Arrayit Corporation (OTC: ARYC), a developer, manufacturer and marketer of proprietary life sciences technologies and consumables for disease prevention, treatment and cure, announces that it has received the most bullish stock rating in the life sciences sector. ARYC has an overall bullish rating of 0.46, which is higher than that of Illumnia Inc. (NASDAQ: ILMN) (0.41), Bruker Corporation (NASDAQ: BRKR) (0.41), Agilent Technologies Inc. (NYSE: A) (0.38), and PerkinElmer Inc. (NYSE: PKI) (0.36). The bullish stock rating, along with a sharp rise in trading volume recently, suggest that ARYC stock price could be headed higher in the near future. ARYC stock has already gained nearly 20% in August so far.
To read more about ARYC and subscribe to a monthly update, CEO interview etc, please click here – http://www.listonstreetpulse.com/tag/ARYC/
About Arrayit Corporation
Arrayit Corporation is a Sunnyvale, California-based company leading and empowering the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development, and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. The company’s innovative products and services help scientists and clinicians explore the human genome as well as the genomes of plants and animals. Arrayit’s products are used by every major research center in the world.
About Liston Street Pulse
Liston Street Pulse is a leading provider of financial research. The company has significant expertise in U.S. listed small cap and micro-cap stocks. Over the years, Liston Street Pulse’s original and unbiased analysis has helped the investor community immensely.
